96728 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tetrapeptides with the first amino acid being heterocyclic
AMINO ACID-MODIFIED LIPIDS FOR RNA DELIVERY
#2INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF
#3INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF
#4NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF
#5ANALOGS THAT TARGET MITOCHONDRIAL DISEASES
#6Method for Synthesizing Amide and/or Polypeptide Using Unprotected Amino Acid as Ammonia Component
#7Method for Preparing a Peptide With CCK Receptor Modulatory Activity
#8STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION
#9COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE CONTAINING NOVEL COMPOUND
#10METHODS FOR REDUCING CD36 EXPRESSION
#11COMPOSITIONS AND METHODS FOR PURIFYING BIOLOGICAL FLUIDS
#12MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE
#13METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#14POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS
#15Protease inhibitors
#1614-3-3 TARGETING PEPTIDES FOR CANCER TREATMENT
#17Polypeptide and its use as a CCK receptor agonist/antagonist
#18ANTIVIRAL LARAZOTIDE DERIVATIVES
#19PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME
#20TETRAPEPTIDE DERIVATIVE,COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF
#21MODULATORS OF SORTILIN ACTIVITY
#22TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES
#23POLYPEPTIDE COMPOUND AND APPLICATION THEREOF
#24MELANOCORTIN LIGANDS AND METHODS OF USE THEREOF
#25COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE DISEASES AND DISORDERS
#2614-3-3 targeting peptides for cancer treatment
#27POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF
#28METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#29METHODS FOR REDUCING CD36 EXPRESSION
#30Melanocortin 1 receptor ligands and methods of use
#31A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS
#32CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS
#33CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS
#34MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#35PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME
#36ALTERNATIVE PROCESSES FOR THE PREPARATION OF TUBULYSINS AND INTERMEDIATES THEREOF
#37COMPOUNDS AND METHODS FOR TREATING CANCER, VIRAL INFECTIONS, AND ALLERGIC CONDITIONS
#38COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#39Non-opioid anti-pain medication
#40Peptides and compositions for use in cosmetics
#41Peptides having inhibitory activity on muscarinic receptor M3
#42PROCESS AND INTERMEDIATES FOR SYNTHESIS OF PEPTIDE COMPOUNDS
#43Therapeutic compounds and methods
#44Analogs that target mitochondrial diseases
#45Rapaglutins, novel inhibitors of GLUT and use thereof
#46COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#47N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
#48Inhibitors of blood coagulation factor XIII
#4914-3-3 targeting peptides for cancer treatment
#50Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
#51Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
#52Methods for reducing CD36 expression
#53Compositions comprising cyclic peptides derived from an A-beta peptide
#54Compounds for proteasome enzyme inhibition
#55ANTIMICROBIAL TETRAPEPTIDES
#56POSITIVE ALLOSTERIC MODULATORS OF GABA A RECEPTOR
#57Conjugate of a tubulysin analog with branched linkers
#58PROCESS AND INTERMEDIATES FOR SYNTHESIS OF PEPTIDE COMPOUNDS
#59Peptide amide compound and preparation method and medical use thereof
#60Small molecule DCN1 inhibitors and therapeutic methods using the same
#61COMPOUNDS FOR PROTEASOME
#62METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#63Growth Hormone Releasing Peptides
#64Melanocortin 1 receptor ligands and methods of use
#65INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF
#66Inhibitors of transglutaminases
#67Water soluble salts of lipidated peptides and methods for preparing and using the same
#68METHODS FOR REDUCING CD36 EXPRESSION
#69Melanocortin receptor-specific peptides
#70COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#71Synthetic peptide amides and dimers thereof
#72Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#73PEPTIDE FOR INHIBITING BINDING OF AMYLOSPHEROIDS (ASPD), AND EVALUATION AND SCREENING METHOD
#74Water-soluble peptide fluorescence material
#75PAR2 mimetic peptides and uses thereof
#76Connective tissue stimulating peptides
#77THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF
#78Antimicrobial peptidomimetics
#79Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#80MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#81N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
#82Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#83Medical Use
#84Method for preventing, improving, or treating inflammatory bowel disease
#85COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#86Prodrugs of peptide epoxy ketone protease inhibitors
#87NMDA receptor modulators and prodrugs, salts, and uses thereof
#88Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
#89Method of using pharmaceutical compositions comprising selective peptide-based agonists of melanocortin 1 receptor
#90Water-soluble peptide fluorescence material
#91Growth Hormone Releasing Peptides
#92NEUROTOXIC TARGET FOR AMYLOSPHEROID, METHOD AND MATERIAL FOR REDUCING THE NEUROTOXICITY OF AMYLOSPHEROID, AND USE THEREOF
#93Peptide analogs of alpha-melanocyte stimulating hormone
#94METHODS FOR REDUCING CD36 EXPRESSION
#95LINEAR PEPTIDE ANTIBIOTICS
#96TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE
#97Compounds for enzyme inhibition
#98TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES
#99Cyclin based inhibitors of CDK2 and CDK4
#100Melanocortin 1 receptor ligands and methods of use
#101Peptide fragments for inducing synthesis of extracellular matrix proteins
#102PAR-1 based therapeutic conjugates and uses thereof
#103PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME
#104Synthetic peptide amides and dimers thereof
#105Methods and compositions related to inhibition of viral entry
#106Antimicrobial peptidomimetics
#107Melanocortin receptor-specific peptides
#108Tubulysin compounds, methods of making and use
#109Prodrugs of peptide epoxy ketone protease inhibitors
#110SELECTIVE INHIBITORS OF PROTEINASE 3
#111NMDA receptor modulators and prodrugs, salts, and uses thereof
#112Connective tissue stimulating peptides
#113Aminostatin derivatives for the treatment of arthrosis
#114BIOACTIVE PEPTIDES AND METHODS OF PRODUCING AND USING THE SAME
#115Agents for the Molecular Imaging of Serine-Protease in Human Pathologies
#116Short peptides and a method of use as an antioxidant
#117METHODS OF MAKING CARFILZOMIB AND INTERMEDIATES THEREOF
#118Method for treatment of GM1 gangliosidosis
#119Peptide analogs of alpha-melanocyte stimulating hormone
#120Tunable control of protein degradation in synthetic and endogenous bacterial systems
#121Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation
#122Short peptides and a method of use as an antioxidant
#123Tetrapeptides and a method of use as an antioxidant
#124TRH binding site in human CNS
#125Anti-inflammatory proteins and peptides and methods of preparation and use thereof
#126Polymers, pharmaceutical compositions and methods of synthesizing the same
#127Skin care compositions and methods comprising selective agonists of melanocortin 1 receptor
#128Pharmaceutical compositions comprising selective peptide-based agonists of melanocortin 1 receptor
#129Mucin hypersecretion inhibitors and methods of use
#130Derivatives of pyridinone as inhibitors for tissue transglutaminase
#131RFamide-related peptides and methods thereof
#132Linear peptide antibiotics
#133Tubulysin compounds, methods of making and use
#134Peptide fragments for inducing synthesis of extracellular matrix proteins
#135PROCESS FOR THE SYNTHESIS OF TELAPREVIR, OR PHARMACEUTICALLY ACCEPTABLE SALTS OR SOLVATES AS WELL AS INTERMEDIATE PRODUCTS THEREOF
#136Growth hormone releasing peptides
#137Cyclin based inhibitors of CDK2 and CDK4
#138Synthetic peptide amides and dimers thereof
#139Melanocortin receptor-specific heptapeptides
#140COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#141Method of treating endometriosis
#142Haprolid and Derivatives Thereof as Inhibitors of HCV
#143Hybrid polypeptides with selectable properties
#144Methods for reducing CD36 expression
#145Tubulysin compounds, methods of making and use
#146Tubulysin compounds, methods of making and use
#147Melanocortin 1 receptor ligands and methods of use
#148Template-fixed peptidomimetics
#149PEPTOID COMPOSITIONS AND METHODS OF USING THE SAME
#150Prodrugs of peptide epoxy ketone protease inhibitors
#151Prodrugs of peptide epoxy ketone protease inhibitors
#152Hydrogel-forming material
#153GRANZYME B INHIBITOR COMPOSITIONS, METHODS AND USES FOR PROMOTING WOUND HEALING
#154Compounds for enzyme inhibition
#155Compounds for enzyme inhibition
#156Compounds for enzyme inhibition
#157Mucin hypersecretion inhibitors and methods of use
#158Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#159Peptide analogs of alpha-melanocyte stimulating hormone
#160Peptide compound useful for inhibiting amyloid plaque formation
#161Methods for preventing or treating mitochondrial permeability transition
#162Linear peptide antibiotics
#163Minimal motifs of linear B-cell epitopes in L1 protein from human papillomavirus type 58 and their applications
#164Inhibitors of Serine Proteases
#165Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof
#166Lipid peptide and hydrogel
#167Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
#168PEPTIDES FOR THE REGULATION OF NEUROTRANSMITTER SEQUESTRATION AND RELEASE
#169Growth hormone releasing peptides
#170RFamide-Related Peptides and Methods Thereof
#171Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same
#172Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
#173COMPOSITIONS AND METHODS FOR INHIBITING MMP-9-MEDIATED CELL MIGRATION
#174INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE
#175Prostaglandin-F2 alpha receptor modulators and uses thereof
#176REGULATION OF AUTOPHAGY PATHWAY PHOSPHORYLATION AND USES THEREOF
#177Hybrid polypeptides with selectable properties
#178Stabilized melanocortin ligands
#179Melanocortin receptor-specific peptides
#180Oligopeptides And Their Use In Cosmetics
#181Human milk peptides
#182Connective tissue stimulating peptides
#183ANTIMICROBIAL, ANTIVIRAL, ANTICANCER AND IMMUNOMODULATORY PEPTIDES AND USES THEREFORE
#184Method of treating tumors
#185Peptide fragments for inducing synthesis of extracellular matrix proteins
#186Lactam-bridged melanocortin receptor-specific peptides
#187Methods for preventing or treating mitochondrial permeability transition
#188G-TYPE PEPTIDES AND OTHER AGENTS TO AMELIORATE ATHEROSCLEROSIS AND OTHER PATHOLOGIES
#189ANTIOXIDANT AGENT
#190HEPATITIS C INHIBITOR COMPOUNDS
#191FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS
#192Peptides
#193Synthetic peptide amides and dimers thereof
#194Michael systems as transglutaminase inhibitors
#195T-cell death-inducing epitopes
#196INHIBITORS OF SERINE PROTEASES
#197Depsipeptides and their therapeutic use
#198Stabilized liquid enzyme compositions
#199Histidine related compounds for identifying and blocking amyloid beta ion channels
#200N-alkylated cyclic peptide melanocortin agonists
#201Methods for reducing CD36 expression
#202PERSONAL CARE AND COSMETIC COMPOSITION CONTAINING TETRAPEPTIDES WITH THE MOTIFS GX1X2G, PX1X2P, OR PX1X2K
#203Epithelial cell growth promoter
#204METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION
#205Lipid peptide and hydrogel
#206Antimicrobial compounds and formulations
#207Conformationally constrained peptide mimetics
#208Organic Compounds and their uses
#209PEPTIDES AND PEPTIDE MIMETICS TO INHIBIT THE ONSET AND/OR PROGRESSION OF FIBROTIC AND/OR PRE-FIBROTIC PATHOLOGIES
#210PEPTIDES AND PEPTIDE MIMETICS TO TREAT CANCER
#211Mucin hypersecretion inhibitors and methods of use
#212PREVENTIVE OR THERAPEUTIC COMPOSITION FOR LIVER DISEASE
#213METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#214Methods and compositions related to inhibition of viral entry
#215INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE
#216Antimicrobial peptides
#217Oligopeptides and their use in cosmetics
#218Influenza infection-inhibiting peptide, influenza virus infection inhibitor, liposome, and influenza preventive/therapeutic agent
#219Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#220Template-fixed peptidomimetics
#221ACE-INHIBITORY PEPTIDES FROM WHEY AND METHODS FOR PROVIDING THE SAME
#222Peptides for the regulation of neurotransmitter sequestration and release
#223REGULATION OF APG8 PHOSPHORYLATION AND USES THEREOF
#224Regulation of autophagy pathway phosphorylation and uses thereof
#225Peptide
#226Peptides Inhibiting Angiotensin-Converting Enzyme
#227Peptides directed for diagnosis and treatment of amyloid-associated diseases
#228CHOLESTEROL LOWERING PROTEIN HYDROLYSATES
#229COMPOUNDS FOR THE INHIBITION OF APOPTOSIS
#230Peptide analogs of alpha-melanocyte stimulating hormone
#231Mucin hypersecretion inhibitors and methods of use
#232Synthetic peptide amide dimers
#233Methods for reducing CD36 expression
#234Reagents and methods for smooth muscle therapies
#235Selective substrates for matrix metalloproteinases
#236Methods and uses for protein breakdown products
#237SMALL PEPTIDIC AND PEPTIDO-MIMETIC AFFINITY LIGANDS FOR FACTOR VIII AND FACTOR VIII-LIKE PROTEINS
#238Compounds for enzyme inhibition
#239Alpha-fetoprotein peptides
#240Reagents and Methods for Smooth Muscle Therapies
#241Reagents and methods for smooth muscle therapies
#242Peptide ligands
#243Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
#244Protective skin care peptides
#245Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use
#246METHODS AND COMPOSITIONS FOR TREATING CONDITIONS
#247Immunoregulatory compositions
#248BIOLOGICALLY ACTIVE PEPTIDES
#249Peptides that antagonize FPR class receptor mediated signaling
#250Acid Addition Salts of Ac-Phscn-Nh2
#251Prodrug compounds with isoleucine
#252Growth hormone releasing peptides
#253Backbone Cyclized Melanocortin Stimulating Hormone (Alpha Msh) Analogs
#254Microcin B17 Analogs And Methods For Their Preparation And Use
#255Biologically active peptide consisting of tyrosyl-seryl-leucine (YSL)
#256Short bio-active peptides for cellular and immunological modulation
#257Activatable photodynamic therapy agents
#258Therapeutic uses of tri-, tetra-, penta-, and polypeptides
#259ABUSE-RESISTANT HYDROCODONE COMPOUNDS, COMPOSITIONS AND METHODS OF USING THE SAME
#260IMMUNOREGULATORY COMPOSITIONS
#261Alpha-fetoprotein peptides and uses thereof
#262PIF tetrapeptides
#263Peptide fragments for inducing synthesis of extracellular matrix proteins
#264Inhibitors of serine proteases, particular HCV NS3-NS4A protease
#265Biologically active peptide PTTKTYFPHF
#266Compounds that modulate TRH actions
#267Synthetic antimicrobial polypeptides
#268Biologically Active Peptides
#269Epithelial cell growth promoter
#270Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
#271Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
#272Compounds for enzyme inhibition
#273Methionine aminopeptidase-2 inhibitors and methods of use thereof
#274Methods for reducing CD36 expression
#275Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#276Compounds for enzyme inhibition
#277Inhibitors of serine proteases
#278Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
#279Novel enterokinase cleavage sequences
#280Methods for preventing or treating ischemia-reperfusion injury of the kidney
#281Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#282Prodrug compounds with isoleucine
#283Methionine aminopeptidase-2 inhibitors and methods of use thereof
#284Beta-sheet mimetics and methods relating to the use thereof
#285Hybrid polypeptides having glucose lowering activity
#286Substances k01-0509 and process for producing the same
#287Biologically active peptides
#288β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
#289Melanocortin Metallopeptode Combinatorial Libraries and Applications
#290Peptides directed for diagnosis and treatment of amyloid-associated disease
#291Method of designing physiologically active peptide and use thereof
#292G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
#293Mucin hypersecretion inhibitors and methods of use
#294Protein and its use in diagnosing Alzheimer's disease
#295Biologically active peptide conjugates
#2962-hydroxytetrahydrofuran derivatives and use thereof as medicaments
#297Peptides and methods for the control of obesity
#298Hybrid polypeptides with selectable properties
#299Methods for accumulating arbitrary peptides in plant protein bodies
#300Synthetic glyco-lipo-peptides as vaccines